DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

13.95 -0.32 (-2.24%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

INFI $13.95 -2.24%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.32
Previous Close $14.27
Daily Range $13.65 - $14.32
52-Week Range $8.40 - $20.51
Market Cap $677.8M
P/E Ratio -4.68
Dividend (Yield) $0.00 (0.0%)
Volume 1,896,008
Average Daily Volume 1,437,619
Current FY EPS -$3.35

Sector

Healthcare

Industry

Drugs

Infinity Pharmaceuticals, Inc. (INFI) Description

The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions. Website: http://www.infi.com/

News & Commentary Rss Feed

Dividend Aristocrats: Time to Buy AbbVie Inc Stock?

AbbVie is an innovative pharma company with an attractive yield and a strong outlook for top-line growth going forward. Here's why investors should dig into this top dividend stock.

Incyte Pharmaceutical: Top Idea For 2H14 With 2 Free Call Options Driving M&A Valuation To $93, Gile

Incyte Pharmaceutical: Top Idea For 2H14 With 2 Free Call Options Driving M&A Valuation To $93, Gilead Most Likely Suitor

Biotech Stock Roundup: AbbVie Ties Up with Infinity, Keryx Slips on FDA Approval - Analyst Blog

Infinity Pharmaceuticals (INFI) Soars: Stock Rises 7.1% - Tale of the Tape

AbbVie Is Betting Big On Infinity Pharmaceuticals But Should You?

Will AbbVie's $805 Million Agreement for Duvelisib Pay Off? - Analyst Blog

Thursday's ETF with Unusual Volume: PBD

Benzinga's Top Upgrades

JMP Securities Upgrades Infinity Pharmaceuticals To Market Outperform

Infinity Pharma (INFI) Shares Skyrocket on Cancer Drug Partnership - Stocks in the News

Infinity Pharma (INFI) Shares Skyrocket on Cancer Drug Partnership - Stocks in the News

See More INFI News...

INFI's Top Competitors

INFI $13.95 (-2.24%)
Current stock: INFI
AMGN $144.01 (1.40%)
Current stock: AMGN
GILD $105.96 (0.03%)
Current stock: GILD
BIIB $329.24 (-0.23%)
Current stock: BIIB